Ignite Creation Date:
2025-12-24 @ 5:42 PM
Ignite Modification Date:
2026-01-19 @ 1:29 AM
Study NCT ID:
NCT02744768
Status:
UNKNOWN
Last Update Posted:
2018-03-22
First Post:
2016-04-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia
Sponsor:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
LAL2116
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None